确定接受R-CHOP治疗的新诊断大B细胞淋巴瘤患者的临床病理预后指数。 - Suppr

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

作者信息

Ni Vincent, Nasta Sunita D, Barta Stefan K, Schuster Stephen J, Chong Elise A, Svoboda Jakub, Morrissette Jennifer J D, Barlev Ashley, Bagg Adam, Priore Salvatore F, Landsburg Daniel J

机构信息

School of Arts and Sciences, University of Pennsylvania, Philadelphia.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.

出版信息

Haematologica. 2025 Apr 1;110(4):1023-1027. doi: 10.3324/haematol.2024.286560. Epub 2024 Nov 28.

DOI:10.3324/haematol.2024.286560

PMID:39605216

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11959230/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ca/11959230/9e23427e54a0/1101023.fig1.jpg

相似文献

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.确定接受R-CHOP治疗的新诊断大B细胞淋巴瘤患者的临床病理预后指数。

Haematologica. 2025 Apr 1;110(4):1023-1027. doi: 10.3324/haematol.2024.286560. Epub 2024 Nov 28.

Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.弥漫大 B 细胞淋巴瘤患者接受 R-CHOP 样或 CHOP 样方案治疗的临床特征和结局：单中心 8 年经验。

Ann Palliat Med. 2020 Jul;9(4):1442-1452. doi: 10.21037/apm-19-589. Epub 2020 Jul 2.

Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.R-CHOP 治疗原发性纵隔大 B 细胞淋巴瘤患者的极低危亚组鉴定。

Oncologist. 2021 Jul;26(7):597-609. doi: 10.1002/onco.13789. Epub 2021 Jun 17.

External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival.在接受 R-CHOP 治疗的弥漫性大 B 细胞淋巴瘤患者中，对 IPI、R-IPI 和 NCCN-IPI 进行外部验证和比较，以预测 2 年无进展生存率。

Hematology. 2022 Dec;27(1):1237-1245. doi: 10.1080/16078454.2022.2147916.

[The prognostic value of the international prognostic index, the national comprehensive cancer network IPI and the age-adjusted IPI in diffuse large B cell lymphoma].[国际预后指数、美国国立综合癌症网络IPI及年龄校正IPI在弥漫性大B细胞淋巴瘤中的预后价值]

Zhonghua Xue Ye Xue Za Zhi. 2018 Sep 14;39(9):739-744. doi: 10.3760/cma.j.issn.0253-2727.2018.09.007.

[A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].新诊断的年轻中/高危弥漫性大B细胞淋巴瘤患者诱导化疗联合或不联合自体造血干细胞移植的比较研究

Zhonghua Xue Ye Xue Za Zhi. 2019 Feb 14;40(2):117-124. doi: 10.3760/cma.j.issn.0253-2727.2019.02.005.

Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.一线R-CHOP化疗部分缓解的弥漫性大B细胞淋巴瘤患者的临床结局：继发性国际预后指数评分和多维尔评分的预后价值

Ann Hematol. 2017 Nov;96(11):1873-1881. doi: 10.1007/s00277-017-3107-6. Epub 2017 Aug 22.

Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.胸膜或心包积液在原发性纵隔大B细胞淋巴瘤中的预后意义及最佳治疗的启示：日本一项多中心回顾性研究

Haematologica. 2014 Dec;99(12):1817-25. doi: 10.3324/haematol.2014.111203. Epub 2014 Sep 12.

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.在接受 CHOP 或 R-CHOP 治疗的弥漫性大 B 细胞淋巴瘤患者中，BCL6 重排与预后的相关性。

Haematologica. 2010 Jan;95(1):96-101. doi: 10.3324/haematol.2009.007203. Epub 2009 Oct 1.

A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 /CD79B diffuse large B-cell lymphoma.一项单中心、真实世界研究，评估 BTK 抑制剂在 MYD88/CD79B 弥漫性大 B 细胞淋巴瘤初始治疗中的疗效。

Cancer Med. 2024 Feb;13(4):e7005. doi: 10.1002/cam4.7005.

本文引用的文献

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma.准确解读 p53 免疫组化模式是大 B 细胞淋巴瘤中 TP53 改变的替代生物标志物。

BMC Cancer. 2023 Oct 19;23(1):1008. doi: 10.1186/s12885-023-11513-x.

TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era.TP53 突变可预测当代新诊断侵袭性 B 细胞淋巴瘤患者的不良预后。

Blood Adv. 2023 Dec 12;7(23):7243-7253. doi: 10.1182/bloodadvances.2023011384.

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤的遗传亚型简化算法。

Signal Transduct Target Ther. 2023 Apr 10;8(1):145. doi: 10.1038/s41392-023-01358-y.

A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients.弥漫性大B细胞淋巴瘤中MYC蛋白表达70%的截断值可识别出高危患者组。

Haematologica. 2020 Nov 1;105(11):2667-2670. doi: 10.3324/haematol.2019.235556.

Prognostic Significance of Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.弥漫性大 B 细胞淋巴瘤中重排和易位伙伴的预后意义：Lunenburg 淋巴瘤生物标志物联盟的研究。

J Clin Oncol. 2019 Dec 10;37(35):3359-3368. doi: 10.1200/JCO.19.00743. Epub 2019 Sep 9.

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.高级别 B 细胞淋巴瘤的分子生物学特征：确定一个不良风险群体，需要采用不同的治疗方法。

J Clin Oncol. 2019 Jan 20;37(3):202-212. doi: 10.1200/JCO.18.01314. Epub 2018 Dec 3.

TP53 mutation and survival in aggressive B cell lymphoma.TP53 突变与侵袭性 B 细胞淋巴瘤患者的生存情况。

Int J Cancer. 2017 Oct 1;141(7):1381-1388. doi: 10.1002/ijc.30838. Epub 2017 Jun 26.

P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.P53表达与弥漫性大B细胞淋巴瘤较差的生存率相关，并增强了MYC重排、表达或同时存在的MYC/BCL2表达的负面预后影响。

Mod Pathol. 2017 Feb;30(2):194-203. doi: 10.1038/modpathol.2016.178. Epub 2016 Oct 14.

Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.一线、剂量递增的免疫化疗与双打击淋巴瘤患者显著的无进展生存优势相关：系统评价和荟萃分析。

Br J Haematol. 2015 Aug;170(4):504-14. doi: 10.1111/bjh.13463. Epub 2015 Apr 24.

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.双打击淋巴瘤中诱导方案和干细胞移植对结局的影响：一项多中心回顾性分析。

Blood. 2014 Oct 9;124(15):2354-61. doi: 10.1182/blood-2014-05-578963. Epub 2014 Aug 26.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献